MyAverix Finance
SA · Healthcare
Bio-Techne Corporation (T1CH34)
Biotechnology
Bio-Techne Corporation (T1CH34) is listed on SA in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $41.96B, P/E ratio is 99.33, net margin is 6.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for T1CH34
Bio-Techne Corporation (T1CH34) — FAQ
What is Bio-Techne Corporation's market cap?
Bio-Techne Corporation (T1CH34) has a reported market cap of $41.96B (data as of 2026-03-29).
What is T1CH34's P/E ratio?
The price-to-earnings (P/E) ratio for Bio-Techne Corporation (T1CH34) is 99.33 (data as of 2026-03-29).
Does Bio-Techne Corporation pay a dividend?
Dividend yield is not available in the current snapshot for Bio-Techne Corporation (T1CH34). Check the MyAverix Finance app for the latest dividend data.
What sector is Bio-Techne Corporation in?
Bio-Techne Corporation (T1CH34) is classified in the Healthcare sector (Biotechnology industry).
What exchange is T1CH34 listed on?
T1CH34 is listed on SA.
What is Bio-Techne Corporation's net margin?
Bio-Techne Corporation (T1CH34) reports a net margin of 6.7% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.